You may also like
Novel Autologous, High Concentrated Fibrin as Advanced Hemostatic Agent for Coronary Surgery
Autologous bio-regenerative fibrin can be safely prepared, with no time consuming, and was demonstrated to be a useful tool to decrease allogeneic blood transfusion requirements following elective coronary artery bypass grafting surgery. A prospective randomized trial is needed to confirm these findings.
1 min read
Removal of Glucose from the Cardiopulmonary Bypass Prime: A Prospective Clinical Audit
The results of our audit provide an evidence base to support our change in practice to utilize nonglucose primes.
1 min read
Managing a Patient with Sickle Cell Anemia and Protein C Deficiency on Cardiopulmonary Bypass (Video)
Meyyappan Arunachalam presents a case report on a patient with sickle cell disease and protein C deficiency (26:49 minutes).
1 min read
